|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9976 USD | +5.01% |
|
-5.89% | -68.82% |
| 07-11 | Revelation Biosciences Adopts Stockholder Rights Plan | MT |
| 05-08 | Revelation Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.08 | 1.41 | 3.253 |
| Spread/Res. | -7.63% | -29.25% | -69.33% |
| Spread/Supp. | +12.86% | +40.21% | +182.69% |
| Support | 0.8839 | 0.7115 | 0.3529 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- REVB Stock
- Charts Revelation Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
